Advertisement
Screener

Pulse Biosciences, Inc. (PLSE) Proceeds from Related Party Debt

2.8 / 5 stars · 68/120 Roast Me

Pulse Biosciences, Inc. Proceeds from Related Party Debt

Pulse Biosciences, Inc. (PLSE) reported Proceeds from Related Party Debt of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromRelatedPartyDebt · last filed 2024-03-28

  • Pulse Biosciences, Inc. proceeds from related party debt for the quarter ending 2023-12-31 was $0.00.
  • Pulse Biosciences, Inc. proceeds from related party debt for the quarter ending 2022-12-31 was $0.00.
  • Pulse Biosciences, Inc. proceeds from related party debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • Pulse Biosciences, Inc. proceeds from related party debt for fiscal 2022 was $65.00M.
  • Pulse Biosciences, Inc. proceeds from related party debt for fiscal 2021 was $0.00.
  • Pulse Biosciences, Inc. proceeds from related party debt for fiscal 2020 was $0.00.
Period endProceeds from Related Party Debt 3 monthProceeds from Related Party Debt 9 monthProceeds from Related Party Debt 12 month
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$0.00
10-K · filed 2024-03-28
2023-09-30$0.00
10-Q · filed 2023-11-13
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$65.00M
10-K · filed 2024-03-28
2022-09-30$65.00M
10-Q · filed 2023-11-13
2021-12-31$0.00
10-K · filed 2023-03-31
2020-12-31$0.00
10-K · filed 2023-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
Heartflow, Inc. (HTFL)United States$4.225B
AtriCure, Inc. (ATRC)United States$3.089B
HAEMONETICS CORP (HAE)United States$4.821B36.52
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87